26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

VI. Insulin and Carbohydrate Metabolism<br />

57<br />

form β-hydroxy-β -methyl glutaryl-CoA (HMG-CoA). As<br />

shown in Figure 3-10 , HMG-CoA is a common intermediate<br />

for the synthesis <strong>of</strong> cholesterol and ketone bodies in the<br />

liver cell. In liver, a deacylating enzyme is present, which<br />

cleaves HMG-CoA to yield AcCoA and free AcAc. This<br />

is the HMG-CoA cycle. The free AcAc then diffuses out<br />

<strong>of</strong> the cell and enters the general circulation. For further<br />

oxidations to occur, AcAc is “ reactivated ” with CoA in<br />

extrahepatic tissues (muscle) by the transfer <strong>of</strong> CoA from<br />

succinyl-CoA to form AcAcCoA. Increased ketogenesis<br />

and ketonemia are the net result <strong>of</strong> alterations in metabolic<br />

pathways or enzymes that favor the accumulation<br />

<strong>of</strong> AcAcCoA. Prime examples are diabetes mellitus and<br />

bovine ketosis.<br />

The increased mobilization and utilization <strong>of</strong> fatty acids<br />

are a well-known requisite for ketogenesis under conditions<br />

<strong>of</strong> starvation and diabetes. Under these same conditions,<br />

lipid synthesis from AcCoA is also depressed. The<br />

net effect <strong>of</strong> either or both <strong>of</strong> these alterations favors the<br />

accumulation <strong>of</strong> AcCoA and thus ketogenesis.<br />

Increased ketogenesis is always associated with an<br />

increased rate <strong>of</strong> gluconeogenesis in association with an<br />

increased activity <strong>of</strong> the key gluconeogenic enzyme, PEPcarboxykinase<br />

(PEP-CK). The increased rate <strong>of</strong> gluconeogenesis<br />

in turn depletes OAA. There is an increase in the<br />

NADH/NAD ratio, which would promote the conversion <strong>of</strong><br />

OAA to malate, thereby depleting OAA. With the depletion<br />

<strong>of</strong> OAA and subsequent OAA deficiency, there is an insufficient<br />

condensing partner for AcCoA for the Kreb’s cycle.<br />

The AcCoA is then readily diverted to ketone bodies.<br />

Hepatic ketogenesis is regulated by the rate limiting<br />

transfer <strong>of</strong> FFA across the mitochondrial membrane.<br />

Carnitine acyl transferase, the enzyme system responsible<br />

for the mitochondrial uptake <strong>of</strong> FFA, is increased in diabetes<br />

and contributes to the ketogenesis.<br />

(e.g., diabetes), depression <strong>of</strong> lipogenesis is a characteristic<br />

finding. When there is adequate glucose oxidation (e.g.,<br />

successful insulin therapy in diabetes), lipid synthesis is<br />

restored and the animal regains its weight.<br />

In those conditions with decreased glucose use or availability<br />

(e.g., diabetes, starvation, ruminant ketosis), there<br />

is an increased release <strong>of</strong> glucose precursors (amino acids)<br />

from muscle and FFA from adipose tissues mediated by<br />

activated hormone-sensitive lipases (HSL) ( Khoo et al .,<br />

1973 ). The amino acids and FFA are transported to the liver<br />

where the amino acids follow gluconeogenic pathways.<br />

Fatty acids follow pathways toward oxidation and ketogenesis<br />

and, additionally, glucagon promotes hepatic ketogenesis.<br />

There is also an underutilization <strong>of</strong> ketones in the<br />

peripheral tissues <strong>of</strong> dogs ( Balasse and Havel, 1971 ; Foster<br />

and McGarry, 1982 ). The net result is an overproduction <strong>of</strong><br />

glucose and ketones in liver and an underutilization <strong>of</strong> both<br />

in the peripheral tissues.<br />

VI . INSULIN AND CARBOHYDRATE<br />

METABOLISM<br />

The internal secretions <strong>of</strong> the anterior pituitary, adrenal<br />

cortex and medulla, and the pancreas are closely associated<br />

with carbohydrate metabolism. The pituitary and adrenal<br />

factors were discussed in Section IV.C, together with glucagon.<br />

More detailed information is available in the chapters<br />

on pituitary and adrenal function. Since the successful<br />

extraction <strong>of</strong> insulin by Banting and Best in 1921, a vast<br />

amount <strong>of</strong> literature has accumulated on its role in carbohydrate<br />

metabolism and continues to this day. The fine<br />

details <strong>of</strong> insulin action are still being studied, and a basic<br />

understanding <strong>of</strong> the major biochemical events that occur<br />

in animals with and without insulin has evolved.<br />

B . Influence <strong>of</strong> Glucose Oxidation on<br />

Lipid Metabolism<br />

In addition to the separation <strong>of</strong> the biochemical pathways<br />

for lipid oxidation and lipid synthesis, an anatomical separation<br />

<strong>of</strong> lipid metabolism is also present. The liver is the<br />

major site <strong>of</strong> fatty acid oxidation and the adipose tissue is<br />

the major site <strong>of</strong> lipid synthesis. Adipose tissue, in vitro,<br />

converts glucose carbons to fatty acids faster than does<br />

liver tissue.<br />

It is well known that, with excessive carbohydrate feeding,<br />

fat depots in the body increase. Fasting, on the other<br />

hand, depresses the respiratory quotient (R.Q.) indicating<br />

that the animal is now using body fat as the energy source.<br />

During fasting, plasma FFA also increase, and when carbohydrate<br />

is supplied, they decrease. The presence <strong>of</strong> glucose<br />

both stimulates lipogenesis and spares fatty acid from<br />

oxidation. In diseases with an inability to utilize glucose<br />

A . Proinsulin and Insulin<br />

The elucidation <strong>of</strong> the insulin structure by Sanger in 1959<br />

was soon followed by the discovery <strong>of</strong> its precursor, proinsulin,<br />

and its structure was quickly known. It has been<br />

the subject <strong>of</strong> many reviews ( Raptis and Dimitriadis, 1985 ;<br />

Steiner, 2004 ). Proinsulin is a single-chain looped polypeptide<br />

linked by disulfide bridges ( Fig. 3-11 ). It varies in<br />

length from 78 amino acid residues in the dog to 86 for<br />

the human, horse, and rat. Its m.w. is near 9000 daltons.<br />

Proinsulin is synthesized in the pancreatic β -cells on the<br />

rough endoplasmic reticulum (RER) and transported and<br />

stored in the secretory granules on the Golgi apparatus.<br />

There, the central connecting polypeptide or C-peptide is<br />

cleaved from the chain by proteolytic enzymes, and the<br />

two linked end fragments are the monomeric insulin molecule.<br />

C-peptide has an m.w. <strong>of</strong> 3600 daltons and is devoid<br />

<strong>of</strong> biological activity.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!